Literature DB >> 15558519

Uromodulin storage diseases: clinical aspects and mechanisms.

Francesco Scolari1, Gianluca Caridi, Luca Rampoldi, Regina Tardanico, Claudia Izzi, Doroti Pirulli, Antonio Amoroso, Giorgio Casari, Gian Marco Ghiggeri.   

Abstract

The recent discovery of mutations in the uromodulin gene ( UMOD ) in patients with medullary cystic kidney disease type 2 (MCKD2), familial juvenile hyperuricemic nephropathy (FJHN), and glomerulocystic kidney disease (GCKD) provides the opportunity for a revision of pathogenic aspects and puts forth the basis for a renewed classification. This review focuses on clinical, pathological, and cell biology advances in UMOD -related pathological states, including a review of the associated clinical conditions described to date in the literature. Overall, 31 UMOD mutations associated with MCKD2 and FJHN (205 patients) and 1 mutation associated with GCKD (3 patients) have been described, with a cluster at exons 4 and 5. Most are missense mutations causing a cysteine change in uromodulin sequence. No differences in clinical symptoms between carriers of cysteine versus polar residue changes have been observed; clinical phenotypes invariably are linked to classic MCKD2/FJHN. A common motif among all reports is that many overlapping symptoms between MCKD2 and FJHN are present, and a separation between these 2 entities seems unwarranted or redundant. Cell experiments with mutant variants indicated a delay in intracellular maturation and export dynamics, with consequent uromodulin storage within the endoplasmic reticulum (ER). Patchy uromodulin deposits in tubule cells were found by means of immunohistochemistry, and electron microscopy showed dense fibrillar material in the ER. Mass spectrometry showed only unmodified uromodulin in urine of patients with UMOD mutations. Lack of uromodulin function(s) is associated with impairments in tubular function, particularly the urine-concentrating process, determining water depletion and hyperuricemia. Intracellular uromodulin trapping within the ER probably has a major role in determining tubulointerstitial fibrosis and renal failure. We propose the definition of uromodulin storage diseases for conditions with proven UMOD mutations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558519     DOI: 10.1053/j.ajkd.2004.08.021

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

Review 1.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

2.  Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

Authors:  Stéphan Troyanov; Catherine Delmas-Frenette; Guillaume Bollée; Sonia Youhanna; Vanessa Bruat; Philip Awadalla; Olivier Devuyst; François Madore
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 8.237

3.  No amelioration of uromodulin maturation and trafficking defect by sodium 4-phenylbutyrate in vivo: studies in mouse models of uromodulin-associated kidney disease.

Authors:  Elisabeth Kemter; Stefanie Sklenak; Birgit Rathkolb; Martin Hrabě de Angelis; Eckhard Wolf; Bernhard Aigner; Ruediger Wanke
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

4.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.

Authors:  Yan Liu; Lan Mo; David S Goldfarb; Andrew P Evan; Fengxia Liang; Saeed R Khan; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-30

5.  Molecular and cellular effects of Tamm-Horsfall protein mutations and their rescue by chemical chaperones.

Authors:  Lijie Ma; Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

6.  Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

Authors:  Guillaume Bollée; Karin Dahan; Martin Flamant; Vincent Morinière; Audrey Pawtowski; Laurence Heidet; Didier Lacombe; Olivier Devuyst; Yves Pirson; Corinne Antignac; Bertrand Knebelmann
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 8.237

Review 7.  From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Authors:  Gopalakrishnan Venkat-Raman; Christine Gast; Anthony Marinaki; Lynnette Fairbanks
Journal:  Pediatr Nephrol       Date:  2016-02-12       Impact factor: 3.714

8.  Tamm-Horsfall protein regulates circulating and renal cytokines by affecting glomerular filtration rate and acting as a urinary cytokine trap.

Authors:  Yan Liu; Tarek M El-Achkar; Xue-Ru Wu
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

Review 9.  Uromodulin (Tamm-Horsfall protein): guardian of urinary and systemic homeostasis.

Authors:  Radmila Micanovic; Kaice LaFavers; Pranav S Garimella; Xue-Ru Wu; Tarek M El-Achkar
Journal:  Nephrol Dial Transplant       Date:  2020-01-01       Impact factor: 5.992

Review 10.  Interstitial calcinosis in renal papillae of genetically engineered mouse models: relation to Randall's plaques.

Authors:  Xue-Ru Wu
Journal:  Urolithiasis       Date:  2014-08-06       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.